Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-50243
J Med Chem 2015 Apr 09;587:2958-2966. doi: 10.1021/jm501873p.
Show Gene links Show Anatomy links

Ensemble-based virtual screening for cannabinoid-like potentiators of the human glycine receptor α1 for the treatment of pain.

Wells MM , Tillman TS , Mowrey DD , Sun T , Xu Y , Tang P .


???displayArticle.abstract???
The human glycine receptors (hGlyRs) are chloride-selective ion channels that mediate inhibitory neurotransmission in the brain stem and spinal cord. They are also targets for compounds of potential use in analgesic therapies. Here, we develop a strategy to discover analgesic drugs via structure-based virtual screening based on the recently published NMR structure of the hGlyR-α1 transmembrane domain (PDB ID: 2M6I ) and the critical role of residue S296 in hGlyR-α1 potentiation by Δ(9)-tetrahydrocannabinol (THC). We screened 1549 FDA-approved drugs in the DrugBank database on an ensemble of 180 hGlyR-α1 structures generated from molecular dynamics simulations of the NMR structure of the hGlyR-α1 transmembrane domain in different lipid environments. Thirteen hit compounds from the screening were selected for functional validation in Xenopus laevis oocytes expressing hGlyR-α1. Only one compound showed no potentiation effects; seven potentiated hGlyR-α1 at a level greater than THC at 1 μM. Our virtual screening protocol is generally applicable to drug targets with lipid-facing binding sites.

???displayArticle.pubmedLink??? 25790278
???displayArticle.pmcLink??? PMC4414066
???displayArticle.link??? J Med Chem
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis
Genes referenced: was

References [+] :
Backman, ChemMine tools: an online service for analyzing and clustering small molecules. 2011, Pubmed